Talk Title: “New Mechanisms — Novel Architectures — Enhanced Performance — Innovative Applications: From Fundamental Research to Advanced Gene and Cell Therapy”

Wenxin Wang is a Full Professor and Science Foundation Ireland Principal Investigator at the Charles Institute of Dermatology, School of Medicine, University College Dublin.

Professor Wang’s research focuses on biomaterials, stem cell therapy, and gene therapy for applications in skin wound healing, cartilage and bone regeneration, dental tissue regeneration, and tissue sealants and adhesives.

His scientific contributions have been widely recognized both nationally and internationally, with 271 peer-reviewed articles published in high-impact journals such as Nature Communications, Nature Reviews Chemistry, Science Advances, Angewandte Chemie, Journal of the American Chemical Society, Chemical Science, ACS Nano, and Nano Letters.

He has also authored 5 book chapters, holds 36 patents, has presented 187 conference abstracts and talks, and has delivered 124 invited/keynote lectures. As an entrepreneur, Professor Wang has founded three biotechnology companies—Vornia Ltd (acquired by Ashland), Blafar Ltd, and Branca Bunús Ltd—which collectively employ over 40 individuals in Ireland. In 2010, he was awarded the Young Scientist Award in Regenerative Medicine by the European Tissue Engineering and Regenerative Medicine Society.

Currently, he serves as a review expert and committee member for 28 international research councils and funding agencies.